Various host factors are involved in the cellular entry of hepatitis C virus (HCV). In addition to the factors previously reported, we discovered that the very-low-density lipoprotein receptor (VLDLR) mediates HCV entry independent of CD81. Culturing Huh7.5 cells under hypoxic conditions significantly increased HCV entry as a result of the expression of VLDLR, which was not expressed under normoxic conditions in this cell line. Ectopic VLDLR expression conferred susceptibility to HCV entry of CD81-deficient Huh7.5 cells. Additionally, VLDLR-mediated HCV entry was not affected by the knockdown of cellular factors known to act as HCV receptors or HCV entry factors. Because VLDLR is expressed in primary human hepatocytes, our results suggest that VLDLR functions in vivo as an HCV receptor independent of canonical CD81-mediated HCV entry.virus entry | VLDLR | CD81 | hypoxia | hepatitis C virus H epatitis C virus (HCV) infects more than 170 million people worldwide and is a major cause of chronic liver disease. The virus persists in 80% of infected individuals and can lead to chronic liver diseases including fibrosis, cirrhosis, steatosis, and hepatocellular carcinoma. HCV, an enveloped positive-stranded virus, enters host cells by using various host factors that function as receptors and mediate endocytosis. Several host factors, including CD81 (1), claudin-1 (CLDN1) (2), occludin (OCLN) (3), and scavenger receptor class B member I (SR-BI) (4), have been identified as receptors. Heparan sulfate glycosaminoglycan represents the first attachment site (5) before the interaction of the virus with these factors. Because all the entry factors are required for productive HCV infection, HCV entry seems to be the result of an orchestrated process involving these factors. Additionally, low-density lipoprotein receptor (LDLR) (6), Niemann-Pic C1-like 1 (NPC1L1) (7), transferrin receptor 1 (TfR1) (8), and epidermal growth factor receptor (EGFR) (9) have been shown to play a role in HCV entry. CD81 was the first factor to be identified as an HCV receptor, and it plays an important role in this process by binding with the HCV envelope glycoprotein E2 (10, 11). Indeed, CD81-deficient cell lines such as HepG2 do not permit the entry of HCV (2, 3).Recent studies have demonstrated that HCV RNA replication in Huh7.5 cells is enhanced under hypoxic conditions (12). Because the oxygen content in liver tissue in vivo is estimated to be lower (with a gradient of 9-3%) than the oxygen content under in vitro culture conditions (13), the HCV life cycle may differ significantly from that observed using in vitro culture systems. The very-low-density lipoprotein receptor (VLDLR) is induced under hypoxic conditions. In turn, this receptor enhances the uptake of low-density lipoproteins (LDLs) and very-low-density lipoproteins (VLDLs) (14), possibly through the recognition of ligands (such as apolipoprotein) that associate with the lipoproteins (15). VLDLR is a type I transmembrane lipoprotein receptor belonging to the LDLR family (16). The expre...